{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:47:20Z","timestamp":1782532040453,"version":"3.54.5"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7478-26","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:12:49Z","timestamp":1782511969000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor Treatment"],"prefix":"10.2169","author":[{"given":"Yosuke","family":"Aoyama","sequence":"first","affiliation":[{"name":"Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Haruyama","sequence":"additional","affiliation":[{"name":"Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Takano","sequence":"additional","affiliation":[{"name":"Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cortes J, Cescon DW, Rugo HS, et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N Engl J Med 387: 217-226, 2022.","DOI":"10.1056\/NEJMoa2202809"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378: 158-168, 2018.","DOI":"10.1056\/NEJMra1703481"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wang F, Shi X, Yu X, et al. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review. Front Endocrinol (Lausanne) 15: 1326684, 2024.","DOI":"10.3389\/fendo.2024.1326684"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fregnani ER, Epstein JB, Blijlevens NMA, et al. MASCC\/ISOO clinical practice statement: management of oral complications of immunotherapy. Support Care Cancer 33: 851, 2025.","DOI":"10.1007\/s00520-025-09806-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab 109: 1657-1683, 2024.","DOI":"10.1210\/clinem\/dgae250"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Haanen J, Obeid M, Spain L, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33: 1217, 2022.","DOI":"10.1016\/j.annonc.2022.10.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hawley JM, Owen LJ, Lockhart SJ, et al. Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance. Clin Chem 62: 1220, 2016.","DOI":"10.1373\/clinchem.2016.255034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stokes FJ, Bailey LM, Ganguli A, et al. Assessment of endogenous, oral and inhaled steroid cross-reactivity in the Roche cortisol immunoassay. Ann Clin Biochem 51: 503, 2014.","DOI":"10.1177\/0004563213509793"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zheng Y, Ding Y, Chen L, et al. Breaking therapeutic barriers in solid tumors: clinical progress of antibody-drug conjugate\/immune checkpoint inhibitor combinations (review). Oncol Rep 54: 124, 2025.","DOI":"10.3892\/or.2025.8956"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7478-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:27:14Z","timestamp":1782530834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7478-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":9,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7478-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7478-26"}}